# Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer

> **NCT00096369** · PHASE2 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 130 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** tamoxifen citrate

## Key facts

- **NCT ID:** NCT00096369
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-02
- **Primary completion:** 2007-03-15
- **Final completion:** 2007-03-15
- **Target enrollment:** 130 (ESTIMATED)
- **Why stopped:** accrual goal not met
- **Last updated:** 2019-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096369, "Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00096369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*